Serum progranulin levels in axial spondyloarthropathy and relationship with clinical features

Didem İldemir Doğangün, Meliha Kasapoğlu Aksoy, Lale Altan

DOI: 10.46497/ArchRheumatol.2022.8542

Issue: Volume 37 - Issue 1 - March 2022
2504 1798

Pregnancy outcomes between pregnant systemic lupus erythematosus patients with clinical remission and those with low disease activity: A comparative study

Worawit Louthrenoo, Thananant Trongkamolthum, Nuntana Kasitanon, Antika Wongthanee

DOI: 10.46497/ArchRheumatol.2022.9140

Issue: Volume 37 - Issue 3 - September 2022
2196 1662

Serum BMP-2 and BMP-4 levels and their relationship with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis

Ali Erhan Özdemirel, Serdar Can Güven, Zühre Sarı Sürmeli, Ayla Özyuvalı, Memet Kurt, Diana Rüstemova, Ayşe Peyman Yalçın Sayan, Hüseyin Tutkan, Şebnem Ataman

DOI: 10.46497/ArchRheumatol.2022.9819

Issue: Volume 37 - Issue 3 - September 2022
2491 1805

The association of urinary plasmin level with renal involvement and disease flare among systemic lupus erythematosus patients

Rasha Fawzy, Mounir Serag, Amal Soliman, Sania Elwia, Samia Mojahed

DOI: 10.46497/ArchRheumatol.2022.9307

Issue: Volume 37 - Issue 4 - December 2022
2034 1606

Insulin resistance and adverse lipid profile in untreated very early rheumatoid arthritis patients: A single-center, cross-sectional study in China

Lu Ye, Xin Zhang, Huaxiang Wu, Yahui Chen, Haibo Zhou, Qiaohong Wang, Weihong Xu

DOI: 10.46497/ArchRheumatol.2022.9117

Issue: Volume 37 - Issue 4 - December 2022
2313 1850

Serum cystatin C and βeta-2 microglobulin as potential biomarkers in children with lupus nephritis

Eman Baraka, Nashwa Hashaad, Walid Abdelhalim, Gehan Elolemy

DOI: 10.46497/ArchRheumatol.2023.8520

Issue: Volume 38 - Issue 1 - March 2023
2005 1593

Muscle architecture in patients with primary Sjögren syndrome

Duygu Tecer, Dilek Eker Büyüksireci, Zafer Günendi, Jale Meray, Feride Göğüs

DOI: 10.46497/ArchRheumatol.2023.9414

Issue: Volume 38 - Issue 1 - March 2023
1858 1626

Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations

Joy Artin, Yumn A. Elsabagh, Laila Rashed, Mohamed A. Hussein

DOI: 10.46497/ArchRheumatol.2023.9638

Issue: Volume 38 - Issue 2 - June 2023
1593 1350

Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis

Fulden Sari, Zilan Bazancir Apaydin, Hakan Apaydin, Mehmet Kayaalp, Abdulsamet Erden, Serdar Can Güven, Berkan Armağan, Ahmet Omma, Orhan Kucuksahin, Şükran Erten

DOI: 10.46497/ArchRheumatol.2023.10183

Issue: Volume 39 - Issue 1 - March 2024
1688 2157

Males and females with scleroderma: A comparative study in a Brazilian sample

Matheus Costa, Igor Jorge, Patricia Martin, Renato Nisihara, Thelma Skare

DOI: 10.46497/ArchRheumatol.2023.10011

Issue: Volume 38 - Issue 4 - December 2023
1485 1105

Correlation between clinical disease activity and sacroiliac magnetic resonance imaging detection in axial spondyloarthropathy

Ozenc Inan, Ebru Aytekin, Yasemin Pekin Dogan, Ilhan Nahit Mutlu, Kübra Aydemir, Nuran Oz, Nil Sayiner Caglar

DOI: 10.46497/ArchRheumatol.2024.10401

Issue: Volume 39 - Issue 1 - March 2024
1779 1208

The relationship between clinical parameters and ultrasonographic enthesitis assessment in patients with spondyloarthritis

Gunay Er, Deniz Palamar, Kenan Akgün, İbrahim Asoğlu, Hidayet Sarı

DOI: 10.46497/ArchRheumatol.2024.10224

Issue: Volume 39 - Issue 2 - June 2024
1781 1047

Difficult-to-treat axial spondyloarthritis patients

Tahir Saygın Öğüt, Funda Erbasan, Mehmet Fatih Şahiner, Mine Nokay, Ayşe Yörük Öğüt, Melis Dilbil, Mustafa Ender Terzioğlu, Veli Yazısız

DOI: 10.46497/ArchRheumatol.2024.10567

Issue: Volume 39 - Issue 3 - September 2024
1766 1385